Therapeutics: Acyl-CoA synthetase short-chain family member 2 (ACSS2)

Cancer

INDICATION: Cancer

Mouse and patient studies suggest inhibiting ACSS2 could help

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE